<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3516">
  <stage>Registered</stage>
  <submitdate>10/04/2012</submitdate>
  <approvaldate>10/04/2012</approvaldate>
  <nctid>NCT01577056</nctid>
  <trial_identification>
    <studytitle>Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils</studytitle>
    <scientifictitle>Effect of Fish Oil Supplementation on Postprandial Lipid Metabolism in Familial Hypercholesterolaemia</scientifictitle>
    <utrn />
    <trialacronym>FIFH</trialacronym>
    <secondaryid>NHMRC1028883</secondaryid>
    <secondaryid>1028883</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hypertriglyceridaemia</healthcondition>
    <healthcondition>Familial Hypercholesterolaemia</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other metabolic disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Human Genetics and Inherited Disorders</conditioncode1>
      <conditioncode2>Other human genetics and inherited disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Other interventions - Fish oil capsule
Treatment: drugs - HMG Coenzyme reductase

Active Comparator: Fish oil - 

Placebo Comparator: Placebo - FH subjects with standard treatment (statin treatment)


Other interventions: Fish oil capsule
4g Omega capsule for 12 weeks

Treatment: drugs: HMG Coenzyme reductase
All FH subjects are on standard statin treatment during study period

</interventions>
    <comparator />
    <control />
    <interventioncode>Other interventions interventions</interventioncode>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Postprandial changes in triglyceride-rich lipoprotein concentrations - Incremental area-under-the-curve (AUC) for triglycerides, apoB-48 and retinyl palmitate</outcome>
      <timepoint>12 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Triglyceride-rich lipoprotein kinetics - Kinetic studies of apoB48 and apoB-100 kinetics</outcome>
      <timepoint>12 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Patients with FH (genetically defined LDL-receptor mutation or Dutch score &gt;8) on
             statin treatment only

          -  Hypertriglyceridaemia on a random blood sample (triglycerides &gt;1.5mml/L)</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Subjects with diabetes mellitus

          -  major systemic illness or use of steroids or other lipid-regulating drugs (such as
             niacin, fibrate and colesevelam)

          -  patients on hypocaloric diets or LDL apheresis; anaemia, haemorrhage and pregnancy.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3>The people assessing the outcomes</masking3>
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/04/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate>1/03/2014</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>WA</recruitmentstate>
    <hospital>School of Medicine &amp; Pharmacology,University of Western Australia - Perth</hospital>
    <postcode>6000 - Perth</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>The University of Western Australia</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>National Health and Medical Research Council, Australia</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to determine whether fish oil supplementation is effective in
      the treatment of abnormal fat metabolism in subjects with elevated cholesterolaemia.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01577056</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dick Chan, Phd</name>
      <address>The University of Western Australia</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Dick Chan, PhD</name>
      <address />
      <phone>61-8-92240268</phone>
      <fax />
      <email>dick.chan@uwa.edu.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>